Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
6.23
+0.35 (5.95%)
At close: Sep 11, 2024, 3:59 PM
6.24
+0.01 (0.16%)
After-hours: Sep 11, 2024, 4:10 PM EDT
Ginkgo Bioworks Holdings Stock Forecast
DNA's stock price has decreased by -92.55% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for DNA stock have an average target of 55.8, with a low estimate of 7.00 and a high estimate of 120. The average target predicts an increase of 795.67% from the current stock price of 6.23.
Analyst Consensus: Sell
Analyst Ratings
The average analyst rating for DNA stock from 6 stock analysts is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Apr '24 | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 2 | 2 | 2 | 2 | 2 |
| Total | 5 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Sell Maintains $0.2 → $7 | Strong Sell | Maintains | $0.2 → $7 | +12.36% | Aug 23, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $32 → $12 | Strong Sell | Maintains | $32 → $12 | +92.62% | Jul 9, 2024 |
| BTIG | BTIG | Strong Sell Maintains $20 → $8 | Strong Sell | Maintains | $20 → $8 | +28.41% | Jun 26, 2024 |
| BTIG | BTIG | Hold → Strong Sell Downgrades n/a | Hold → Strong Sell | Downgrades | n/a | n/a | May 15, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $80 → $40 | Hold | Maintains | $80 → $40 | +542.05% | May 15, 2024 |
Financial Forecast
Revenue This Year
186.18M
from 251.46M
Decreased by -25.96%
Revenue Next Year
217.25M
from 186.18M
Increased by 16.69%
EPS This Year
-12.46
from -18.40
EPS Next Year
-7.25
from -12.46
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 199.5M | 248.0M | 315.5M | |
| Avg | 186.2M | 217.3M | 284.5M | |
| Low | 176.7M | 181.3M | 257.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -20.7% | 33.2% | 45.2% | |
| Avg | -26.0% | 16.7% | 31.0% | |
| Low | -29.7% | -2.6% | 18.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -11.76 | -6.30 | -2.10 | |
| Avg | -12.46 | -7.25 | -4.86 | |
| Low | -12.94 | -9.00 | -8.06 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.